Solara Active Pharma, Aurore Life Sciences combine to create second largest Pure Play API / CRAMs company in India

10 Apr 2021 Evaluate

Solara Active Pharma Sciences’ (Solara) Board of Directors has accepted the recommendations of the Committee of Independent Directors and Audit Committee and approved the amalgamation of Aurore, Empyrean and Hydra with Solara. The combination creates a pure play API company of scale with strong presence in Regulated Markets, Emerging Markets, a broad product portfolio, robust operations infrastructure, excellent R&D capabilities and clear synergies to further accelerate growth for the combined entity.

The merger is EPS accretive to Solara and will enhance other important financial ratios for Solara. The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions. The combined entity will have the scale of market presence and product portfolio combined with robust manufacturing and R&D infrastructure to grow into a leading global pure play API and CRAMS company.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. The company has a legacy of over three decades and traces its origins to the API expertise of Strides Shasun. and the technical knowhow of human API business from Sequent Scientific Ltd. 

Solara Active Pharma Share Price

505.05 -4.35 (-0.85%)
28-Apr-2025 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.15
Dr. Reddys Lab 1173.60
Cipla 1529.45
Lupin 2019.00
Zydus Lifesciences 860.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...